Fostamatinib successfully targets the B-cell receptorDecember 13, 2009Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Panobinostat shows promise in refractory Hodgkin lymphomaDecember 9, 2009Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Ofatumumab receives accelerated approval from FDAOctober 27, 2009Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Survival improves for AYAs with leukemia and lymphomaAugust 25, 2009Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Potential cause of R-CHOP failure ruled outMarch 11, 2009Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Novel agent more effective than standard therapy in NHLNovember 17, 2008Lymphoma & Plasma Cell Disorders
